Targeting Leukostasis for the Treatment of Early Diabetic Retinopathy
The DOI matches its Crossref record.
Abstract
Leukocyte-endothelial interaction plays an important role in the early phase of the development of diabetic retinopathy. It has been studied extensively linking inflammatory processes to its development conducted to date in rats and mice, and have focused on insulin-deficient models. The molecular and functional changes that are characteristics of inflammation have been detected in retinas from diabetic animals and humans with involvement of multiple pathways that results in the final sequelae of increased permeability of the blood retinal barrier and finally ischemia that drives angiogenesis. Increased expression of Intracellular adhesion molecules heralds the onset of changes that results in attraction of leucocytes such as neutrophils. The consequent release of cytokines and growth factors such as vascular endothelial growth factor (VEGF), tumor necrosis factor-alpha, and interleukin 1-Beta results in increased permeability and retinal edema. Other indirect mediators involved include pathways such as the protein kinase C (PKC), renin-angiotensin system, enzymes such as the poly ADP-ribose polymerase, 3-hydroxy-3-methylglutaryl-coenzyme A reductase, nitric oxide synthetase and finally advanced glycation products. Therapy for early diabetic retinopathy may inhibit one or more of these pathways using drugs that can be given systemically, with local ocular applications having a more direct effect as in other eye diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Angiogenesis and Inflammation Crosstalk in Diabetic Retinopathy
Capitão, M., & Soares, R. (2016) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25575 · Cited by 312
The MAPK signaling pathway mediates the GPR91-dependent release of VEGF from RGC-5 cells
HU, J., LI, T., DU, S., CHEN, Y., WANG, S., XIONG, F., & WU, Q. (2015) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2015.2195 · Cited by 48
Henriques, J., Vaz-Pereira, S., Nascimento, J., & Rosa, P. C. (2015) · Acta Médica Portuguesa · doi:10.20344/amp.5361 · Cited by 33
Liu, W., Tzeng, T.-F., & Liu, I.-M. (2016) · Molecules · doi:10.3390/molecules21121708 · Cited by 30
“There is growing evidence that leukocyte adhesion to the retinal vasculature or retinal leukostasis results in BRB breakdown in early DR [26,27].”
Background
Metadata
- Authors
- Patel, N.
- Venue
- Cardiovascular & Hematological Disorders-Drug Targets
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2009-09-01
- Volume
- 9
- Issue
- 3
- Pages
- 222-229
- ISSN
- 1568-0061 (ISSN-L)
- 1871-529X
- OpenAlex
- W2047233194
- Cited by
- 50
- References
- 0
- FWCI
- 1.90
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Targeting Leukostasis for the Treatment of Early Diabetic Retinopathy. https://app.cochat.ai/papers/10.2174/187152909789007052
- The paper
- Patel, N. (2009). Targeting Leukostasis for the Treatment of Early Diabetic Retinopathy. Cardiovascular & Hematological Disorders-Drug Targets. https://doi.org/10.2174/187152909789007052
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.